Xue James Qun - Net Worth and Insider Trading

Xue James Qun Net Worth

The estimated net worth of Xue James Qun is at least $8 Million dollars as of 2025-04-30. Xue James Qun is the 2101 Beneficial owner of Canbridge Pharmaceuticals Inc and owns about 56,186,411 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) stock worth over $8 Million. Details can be seen in Xue James Qun's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Xue James Qun has not made any transactions after 2024-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Xue James Qun

Xue James Qun Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Xue James Qun owns 1 companies in total, including Canbridge Pharmaceuticals Inc (HKSE:01228) .

Click here to see the complete history of Xue James Qun’s form 4 insider trades.

Insider Ownership Summary of Xue James Qun

Ticker	Company	Transaction Date	Type of Owner
HKSE:01228	Canbridge Pharmaceuticals Inc	2025-01-09	2101 Beneficial owner

Xue James Qun Latest Holdings Summary

Xue James Qun currently owns a total of 1 stock. Xue James Qun owns 56,186,411 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) as of December 12, 2024, with a value of $8 Million.

Latest Holdings of Xue James Qun

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01228	Canbridge Pharmaceuticals Inc	2024-12-12	56,186,411	0.15	8,371,775

Holding Weightings of Xue James Qun

Xue James Qun Form 4 Trading Tracker

According to the SEC Form 4 filings, Xue James Qun has made a total of 6 transactions in Canbridge Pharmaceuticals Inc (HKSE:01228) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Canbridge Pharmaceuticals Inc is the sale of 4,055 shares on December 12, 2024, which brought Xue James Qun around $0.

Insider Trading History of Xue James Qun

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Xue James Qun Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Xue James Qun Ownership Network

Ownership Network List of Xue James Qun

No Data

Ownership Network Relation of Xue James Qun

Xue James Qun Owned Company Details

What does Canbridge Pharmaceuticals Inc do?

Who are the key executives at Canbridge Pharmaceuticals Inc?

Xue James Qun is the 2101 Beneficial owner of Canbridge Pharmaceuticals Inc. Other key executives at Canbridge Pharmaceuticals Inc include 2201 Interest of corporation controlled by you Qiming Corporate GP IV, Ltd. , 2201 Interest of corporation controlled by you Qiming GP IV, L.P. , and 2101 Beneficial owner Qiming Venture Partners IV, L.P. .

Canbridge Pharmaceuticals Inc (HKSE:01228) Insider Trades Summary

Over the past 18 months, Xue James Qun made 4 insider transaction in Canbridge Pharmaceuticals Inc (HKSE:01228) with a net sale of 0. Other recent insider transactions involving Canbridge Pharmaceuticals Inc (HKSE:01228) include a net purchase of 19,516,700 shares made by JPMorgan Chase & Co. , a net sale of 1,147,630 shares made by Qiming GP IV, L.P. , and a net sale of 1,147,630 shares made by Qiming Venture Partners IV, L.P. .

In summary, during the past 3 months, insiders sold 2,962,260 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) in total and bought 0 shares, with a net sale of 2,962,260 shares. During the past 18 months, 2,962,260 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) were sold and 218,054,686 shares were bought by its insiders, resulting in a net purchase of 215,092,426 shares.

Canbridge Pharmaceuticals Inc (HKSE:01228)'s detailed insider trading history can be found in Insider Trading Tracker table.

Canbridge Pharmaceuticals Inc Insider Transactions

No Available Data

Xue James Qun Mailing Address

Above is the net worth, insider trading, and ownership report for Xue James Qun. Currently GuruFocus does not have mailing address information for Xue James Qun.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.